Critical Care

official impact factor 4.60

Open Access Highly Access Research

Drotrecogin alfa (activated): real-life use and outcomes for the UK

Kathryn M Rowan*, Catherine A Welch, Emma North and David A Harrison

Critical Care 2008, 12:R58 doi:10.1186/cc6879

No comments have yet been made on this article.

Post a comment